Breast Cancer Clinical Trials in Chicago

Showing 461-480 of 556 trials

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

NCT00290758

This randomized phase II trial is studying how well genistein works in preventing breast cancer in women at high risk for breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of genistein may prevent breast cancer in women at high risk for breast cancer.

Breast Cancer

National Cancer Institute (NCI)126 participantsStarted Jan 2006

Chicago, Illinois, United States

COMPLETED2.2 miles

Immediate Postmastectomy Breast Reconstruction (Strattice Breast)

NCT00619762

This prospective, multicenter, open-label study will assess the clinical outcomes of the LTM product in three planned analyses. The primary objective of this study is to prospectively assess the clinical outcomes associated with the use of LTM in two-stage (expander then permanent implant) immediate post-mastectomy breast reconstruction.

Breast Cancer

LifeCell17 participantsStarted Oct 2007

Washington D.C., District of Columbia, United States • Chicago, Illinois, United States • Great Neck, New York, United States +2 more locations

COMPLETEDPhase 22.2 miles

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

NCT00303108

The purpose of this study is to determine the ORR associated with Doxil in combination with carboplatin in HER2- (negative) MBC (and with Herceptin in HER2+ MBC).

Metastatic Breast Cancer

US Oncology Research136 participantsStarted Dec 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sedona, Arizona, United States +54 more locations

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Immediate Postmastectomy Breast Reconstruction (Strattice Breast)

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Ixabepilone + Carboplatin Metastatic Breast Cancer

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer

Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

A Biological Sample Collection Protocol of Women With and Without Breast Cancer

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Other Conditions in Chicago